Crossmark

CD137 agonist potentiates the abscopal efficacy of nanoparticle-based photothermal therapy for melanoma

Published Online: 2021-10-12

Published Print: 2022-03

Authors

Balakrishnan, Preethi Bala

Ledezma, Debbie K.

Cano-Mejia, Juliana

Andricovich, Jaclyn

Palmer, Erica

Patel, Vishal A.

Latham, Patricia S.

Yvon, Eric S.

Villagra, Alejandro

Fernandes, Rohan

Sweeney, Elizabeth E.
License Information

Text and Data Mining valid from 2021-10-12

Version of Record valid from 2021-10-12
More Information

Article History

Received: 8 June 2021

Revised: 6 August 2021

Accepted: 12 August 2021

First Online: 12 October 2021

Document is current